Diabetes Medicine Glipizide May Raise Heart Disease Risk Study Finds | Type 2 diabetes drug global threatens heart

Diabetes Medicine and Heart Health: Crores of people eat medicines daily to control diabetes. Type 2 diabetes patients usually take medicine, so that the blood sugar level is under control. Many diabetes drugs are being sold in the market, which doctors appreciate according to the patient’s needs. Sugar control drugs are generally considered safe, but a recent study revealed that the drug given to type 2 diabetes patients can be dangerous for the heart. This medicine is given the most to diabetes patients in America. This medicine is also used in many other countries. If you are also taking this medicine, then you need to be careful.

The new study claimed that the drug used for type 2 diabetes can damage the gelpizide heart. This medicine is given a lot to diabetes patients in America. It has been revealed in the study that the risk of heart diseases is more than that of other patients taking global diseases. According to the researchers, sulfonyaluria drugs of type 2 diabetes are cheap and popular, but what is the effect on their heart for a long time, it is less information. On the other hand, medicines like DPP-4 inhibitors are considered more secure for the heart. Therefore, patients should get complete information from the doctor before taking diabetes medicines.

This study has been done by the researchers of Mass General Brigham and data of about 50,000 patients was seen, who were taking different sulfonyiluria drugs. He found that the risk of heart disease, hospitalization and death among those taking glipies was more than dye peptidile peptidage-4 i.e. DPP-4 drugs. According to this study researcher and endocronologist Alexander Torchin, patients with type 2 diabetes are at greater risk of serious diseases like stroke and cardiac arrest. The results of this research have been published in a medical journal called Jama Network Open.

In this study, 48165 type 2 diabetes patients were included, whose heart’s risk was moderate and who were undergoing treatment in 10 different hospitals in the country. It was seen in the study that how the patients who were taking sulfonyluria or DPP-4 inhibitors with Metformin, how was the risk of heart diseases for five years. As a result, it was revealed that the risk of heart disease among those taking glipies was 13 percent higher than the DPP-4 inhibitor, while the effects of glimpyride and gliaburide were less pronounced. Researchers said that it is also necessary to investigate why glypizide affects the heart. Type 2 diabetes is growing rapidly. Patients associated with this disease are more at risk of serious heart diseases, so prevention of these diseases is also necessary.